CuraTeQ Biologics, a part of Aurobindo Pharma, has secured a crucial approval from Health Canada for its biosimilar drug Dyrupeg. This medi...

The deal gives AstraZeneca a foothold in the radiopharmaceutical drugs market, which has seen increasing investor interest since 2021 when ...

JPL holds a 25.8% stake in Sofie Biosciences, which it acquired through its Singapore-based subsidiary Jubilant Pharma in November 2020 for...

The event was attended by the heads and leading scientists of the largest research medical centers, manufacturers of medical radioisotopes ...

Total expenses in the first quarter were at Rs 1,568.9 crore, as compared to Rs 1,393.8 crore in the corresponding period a year ago.

In-principle approval has been accorded to a site in Maharashtra's Jaitapur for setting up six nuclear power reactors of 1,650 MW each in t...

Sharp stock price correction, strong growth rates, focus on the growing speciality pharma segment, a bouquet of niche products, among other...

Pharma company Jubilant Life Sciences is planning to invest Rs 300 crore in research and development (R&D) in FY19.

The acquired radiopharmacies will continue to operate independently under the brand name of Triad Isotopes.

The acquisition will be funded through JPL's internal accruals and is likely to be earnings accretive in the first full year of operations,...

Jubilant Life Sciences is engaged in pharmaceuticals, life science ingredients and drug discovery solutions.

Drug firm Jubilant Life Sciences' board will meet on Thursday to consider a proposal to raise about Rs 1,300 crore through issuance of secu...

Fortis said it will explore other “value unlocking opportunities” for RadLink, a provider of outpatient diagnostic imaging, nuclear medicin...

Its net sales stood at Rs 1,430.25 crore during the period, marginal increase of 0.18 per cent per cent compared to Rs 1,427.65 crore y-o-y.

Germany’s Siemens AG is finalising plans to manufacture radiopharmaceuticals (nuclear medicines) in India.

Pharmaceutical firm Jubilant Organosys has completed the acquisition of Canada-based Draxis Speciality Pharmaceuticals Inc for about Rs 1,0...

Jubilant Organosys Ltd and DRAXIS Health Inc. have entered into an agreement whereby a wholly-owned subsidiary of Jubilant will acquire all...